CAS 42017-89-0
:Fenofibric acid
Description:
Fenofibric acid is a synthetic compound primarily used as a lipid-regulating agent, particularly in the treatment of dyslipidemia. It is the active metabolite of fenofibrate and belongs to the class of fibrates, which are known to lower triglyceride levels and increase high-density lipoprotein (HDL) cholesterol. The chemical structure of fenofibric acid features a phenolic group and a carboxylic acid, contributing to its solubility and biological activity. It is typically administered in oral form and is well-absorbed in the gastrointestinal tract. The pharmacological action of fenofibric acid involves the activation of peroxisome proliferator-activated receptors (PPARs), which play a crucial role in lipid metabolism. Common side effects may include gastrointestinal disturbances, muscle pain, and liver enzyme alterations. Fenofibric acid is often used in conjunction with dietary modifications to enhance its lipid-lowering effects. Its safety profile and efficacy have been established through various clinical studies, making it a valuable option in managing cholesterol levels and reducing cardiovascular risk.
Formula:C17H15ClO4
InChI:InChI=1S/C17H15ClO4/c1-17(2,16(20)21)22-14-9-5-12(6-10-14)15(19)11-3-7-13(18)8-4-11/h3-10H,1-2H3,(H,20,21)
InChI key:InChIKey=MQOBSOSZFYZQOK-UHFFFAOYSA-N
SMILES:C(=O)(C1=CC=C(OC(C(O)=O)(C)C)C=C1)C2=CC=C(Cl)C=C2
Synonyms:- 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid
- 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-Propanoic acid
- 2-[4′-(p-Chlorobenzoyl)phenoxy]-2-methylpropionic acid
- 2-[p-(p-Chlorobenzoyl)phenoxy]-2-methylpropionic acid
- 2-{4-[(4-Chlorophenyl)Carbonyl]Phenoxy}-2-Methylpropanoate
- FA
- FNF acid
- Fenofibrate Acid
- Fenofibric acid
- LF 178 acid
- Lf 153
- NSC 281318
- Procetofenic acid
- Propanoic acid, 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 18 products.
Fenofibric Acid
CAS:Formula:C17H15ClO4Purity:>98.0%(GC)(T)Color and Shape:White to Almost white powder to crystalMolecular weight:318.75Fenofibrate Related Compound B (2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormula:C17H15ClO4Color and Shape:White PowderMolecular weight:318.06589Fenofibric Acid (2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormula:C17H15ClO4Color and Shape:White Cream PowderMolecular weight:318.06589Fenofibric acid
CAS:<p>Fenofibric acid (FNF acid) is the active form of fenofibrate, a synthetic phenoxy-isobutyric acid derivate with antihyperlipidemic activity.</p>Formula:C17H15ClO4Purity:99.36%Color and Shape:White Or Almost White Crystalline PowderMolecular weight:318.75Fenofibric acid
CAS:Fenofibric acidFormula:C17H15ClO4Purity:98%Color and Shape: white solidMolecular weight:318.75g/molFenofibric acid, 10mM (in DMSO)
CAS:Fenofibric acid, 10mM (in DMSO)Purity:≥98%Molecular weight:318.75g/molFenofibric acid
CAS:Formula:C17H15ClO4Purity:≥ 98.0% (anhydrous basis)Color and Shape:White to off-white crystalline powderMolecular weight:318.75Fenofibrate EP Impurity B (Fenofibrate USP Related Compound B, Fenofibric Acid)
CAS:Formula:C17H15ClO4Color and Shape:White To Off-White SolidMolecular weight:318.75Fenofibric acid 100 µg/mL in Acetonitrile
CAS:Controlled ProductFormula:C17H15ClO4Color and Shape:Single SolutionMolecular weight:318.75Fenofibrate Impurity 6
CAS:Formula:C23H29NO5Color and Shape:White To Off-White SolidMolecular weight:399.49Fenofibric acid
CAS:<p>Fenofibric acid is a fibrate drug. It is used in the treatment of hypercholesterolemia, including combined with statins and other lipid-lowering drugs. Fenofibric acid has been shown to reduce plasma triglycerides and LDL cholesterol levels. It also reduces atherosclerotic plaque formation by suppressing macrophage accumulation in lesions. Fenofibric acid has been shown to inhibit ATP binding cassette transporter A1 (ABCA1) activity, which may contribute to its ability to increase HDL cholesterol levels.</p>Formula:C17H15ClO4Purity:Min. 95%Color and Shape:PowderMolecular weight:318.75 g/mol2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid
CAS:Formula:C17H15ClO4Purity:98%Color and Shape:SolidMolecular weight:318.75














